Please use this identifier to cite or link to this item:
https://doi.org/10.4155/fsoa-2017-0050
| Title: | Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard | Authors: | Vellayappan, B.A Halasz, L.M Knisely, J.P Chang, E.L Lo, S.S |
Keywords: | bevacizumab lomustine methylated DNA protein cysteine methyltransferase temozolomide cancer growth cancer radiotherapy clinical trial (topic) elderly care glioblastoma human methylation multimodality cancer therapy overall survival priority journal randomized controlled trial (topic) Review |
Issue Date: | 2017 | Citation: | Vellayappan, B.A, Halasz, L.M, Knisely, J.P, Chang, E.L, Lo, S.S (2017). Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: Setting a new standard. Future Science OA 3 (3) : FSO210. ScholarBank@NUS Repository. https://doi.org/10.4155/fsoa-2017-0050 | Rights: | Attribution 4.0 International | Abstract: | [No abstract available] | Source Title: | Future Science OA | URI: | https://scholarbank.nus.edu.sg/handle/10635/178715 | ISSN: | 20565623 | DOI: | 10.4155/fsoa-2017-0050 | Rights: | Attribution 4.0 International |
| Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 10_4155_fsoa-2017-0050.pdf | 1.12 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License
